KMT2A and acute lymphoblastic leukemia: Among adult ALL patients, the most common mutations are kinase-activating fusions (90% of ALL adults), MLL gene rearrangement (10% of all ALL adults), and Notch signaling pathway mutations (10% of ALL adults) [22,23].